Do β2-agonists improve outcomes in patients with acute bronchitis without underlying lung disease?

V Huynh, K Mailland, G Ohning - Evidence-Based Practice, 2021 - journals.lww.com
… examined the use of b2-agonists for cough in acute bronchitis in patients without underlying
lung … Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis (review). …

[HTML][HTML] Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease

K Onishi - Journal of cardiology, 2017 - Elsevier
… Inhaled long-acting bronchodilators including beta2-agonists and anticholinergics for
COPD would not worsen HF. Diuretics are relatively safe, and angiotensin-converting enzyme …

[HTML][HTML] Acute bronchitis

A Singh, A Avula, E Zahn - 2017 - europepmc.org
… cases of viral acute bronchitis. Despite these recommendations, many patients diagnosed
with acute bronchitis are prescribed … Beta2-agonists for acute cough or a clinical diagnosis of …

Japanese guidelines for childhood asthma 2020

H Arakawa, Y Adachi, M Ebisawa… - Allergology …, 2020 - jstage.jst.go.jp
… according to the response to short acting beta2 agonists or the effect of a therapeutic trial …
In JPGL2017, the transdermal patch and oral beta2 agonists are positioned as drugs within …

[HTML][HTML] Vanishing lung syndrome

SKD Shah, MR Lokesh, NN Hegde - 2018 - rjmahs.org
… So the patient was given only supportive treatment with beta2 agonists, Glucocorticoids, …
The condition often occurs six months to five years after viral bronchitis, or follows tuberculosis …

Differences in real-world health and economic outcomes among patients with COPD treated with combination tiotropium/olodaterol versus triple therapy

SR Palli, M Frazer, M DuCharme, AR Buikema… - Journal of Managed …, 2020 - jmcp.org
… antagonists (LAMAs) plus long-acting beta2-agonists (LABAs) for patients in Groups BD who
… a diagnosis code for pneumonia and/or acute bronchitis/bronchiolitis in any position (codes …

The use of life-saving extracorporeal membrane oxygenation (ECMO) for pregnant woman with status asthmaticus

C Steinack, R Lenherr, H Hendra, D Franzen - Journal of Asthma, 2017 - Taylor & Francis
… Despite rescue therapies such as pressure control ventilation with high inspiratory
pressures, inhaled beta2 agonists and antimuscarinic drugs, intravenous salbutamol, …

[HTML][HTML] Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison

C Gulea, R Zakeri, V Alderman, A Morgan, J Ross… - Respiratory …, 2021 - Springer
… one study only reporting an increase in mortality risk associated with beta-blockers (HR:
1.19, 95% CI 1.04 to 1.37); however the population assessed in this report consisted of severe

Cost-effectiveness of treatments for COPD

G Cope - British Journal of Healthcare Management, 2016 - magonlinelibrary.com
… An inhaled corticosteroid combined with a long acting beta2-agonists is more effective than
… and mortality in patients with moderate-to-severe COPD, although there is an increased risk …

Asthma and Anaphylaxis—interconnected entities

R López-Rodríguez, C Gómez-Fariñas… - … Treatment Options in …, 2022 - Springer
… Asthmatic crisis and anaphylaxis require a rapid and early approach, with beta2-agonists
and adrenaline being the initial treatments of choice. We must consider their …